300
Participants
Start Date
February 28, 2006
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
Henogen HBV vaccine
20µg, Month 0, 2 and 6
FENDRIX
20 µg,Months 0, 1, 2 and 6
St. Rókus Hospital, Budapest
AZ -VUB Dienst Nefrologie, Brussels
St. István Hospital, Budapest
Cliniques universitaires Saint Luc, Brussels
Pest County Flór Ferenc Hospital, Kistarcsa
UZ Gasthuisberg Leuven Nierziekten, Leuven
CHU Hôpital civil de, Charleroi
CHU Andre VESALE, Montigny-le-Tilleul
CHU Tivoli, La Louvière
RHMS Clinique Louis Caty Baudour, Baudour
RHMS TournayService de néphrologie, Tournai
RHMS La Madeleine ATH, Ath
UZ Gent, Ghent
O.L.Vrouwziekenhuis Aalst, Aalst
Vas and Szombathely County Markusovszky Hospital, Szombathely
Regional Hospital Liberec, Liberec
CHU Brugmann (site V Horta) Service de néphrologie, Brussels
ULB Hôpital Erasme Département de Néphrologie, Brussels
UZ AntwerpenDienst nefrologie, Edegem
Dept. of Heamodialysis Hospital JihlavaVrchlického, Jihlava
Infection Diseases and AIDS Treatment ClinicUniversity Hospital with Outpatient Clinic, Ostrava - Poruba
Dept. of Internal Medicine StrahovSermirska 5, Prague
Masaryk´s Hospital Socialni pece 3316/12A, Ústí nad Labem
Petz Aladár Teaching Hospital Vasvári, Győr
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Henogen
INDUSTRY